Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2012
09/18/2012US8268560 Polymide nucleic acid derivatives, and agents and processes for preparing them
09/18/2012US8268555 Method for combined sequential agent delivery and electroporation for cell structures and use thereof
09/18/2012US8268362 Insoluble thrombocyte fragments capable of releasing growth factors prepared by freeze drying and subjected to virus partitioning or deactivation
09/18/2012US8268357 Processes for the preparation of lipophilic drug delivery vehicles
09/18/2012US8268348 Combinations and modes of administration of therapeutic agents and combination therapy
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012US8268324 Modified galectin 9 proteins and use thereof
09/18/2012US8268313 Methods for using inhibitors of vascular endothelial growth factor activity
09/18/2012US8268308 Means for the diagnosis and therapy of CTCL
09/18/2012US8268306 Pesticidal and antiparasitic compositions
09/18/2012US8268305 Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
09/18/2012US8268304 Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
09/18/2012US8268294 Photostabilization of retinoids with alkoxycrylene compounds
09/18/2012US8267982 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
09/18/2012CA2700055C Truncated secretory aspartyl proteinase 2
09/18/2012CA2598078C Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
09/18/2012CA2580448C Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3-[etval]4-cyclosporin
09/18/2012CA2533321C Bicyclic peptide imaging agents
09/18/2012CA2532487C Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances, and a method for producing said pharmaceutical dosage form
09/18/2012CA2529742C Composition of a vegf antagonist and an anti-proliferative agent
09/18/2012CA2517274C Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
09/18/2012CA2514303C Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
09/18/2012CA2493165C Oral composition with enhanced organoleptic properties comprising an enzyme and cyclodextrin
09/18/2012CA2480226C Stable pharmaceutical composition containing factor viii
09/18/2012CA2462610C Specific binding agents of human angiopoietin-2
09/18/2012CA2454750C Immunologically significant herpes simplex virus antigens and methods for using same
09/18/2012CA2451133C Therapeutic agent for sepsis
09/18/2012CA2445746C Chimeric immunoreceptor useful in treating human cancers
09/18/2012CA2443702C Echinocandin process
09/18/2012CA2410662C Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
09/18/2012CA2388733C Food supplement for increasing lean mass and strength
09/18/2012CA2383136C Obg3 globular head and uses thereof for decreasing body mass
09/18/2012CA2378943C Super-active porcine growth hormone releasing hormone analog
09/18/2012CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia
09/18/2012CA2330313C Immunization against and treatment for infection by h.pylori
09/18/2012CA2296750C Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation
09/18/2012CA2291483C Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
09/18/2012CA2279554C Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
09/18/2012CA2272051C Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
09/18/2012CA2226013C Preparations and methods for the treatment of t cell mediated diseases
09/13/2012WO2012122519A2 Ligands to the membrane protein caveolin
09/13/2012WO2012122515A1 Treatment of disorders with altered vascular barrier function
09/13/2012WO2012122464A1 Methods and compositions for modulating tnf/tnfr signaling
09/13/2012WO2012122429A2 Helium charged refrigerator
09/13/2012WO2012122422A2 Active agent prodrugs with heterocyclic linkers
09/13/2012WO2012122334A2 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
09/13/2012WO2012122326A1 Engineered bacteria for oral delivery of glucoregulatory proteins
09/13/2012WO2012122107A2 Apparatus, system, and method for creating biologically protected/enhanced spaces in vivo
09/13/2012WO2012122059A1 Hydrogen bond surrogate macrocycles as modulators of ras
09/13/2012WO2012122044A2 Flowable collagen-based hemostat and methods of use
09/13/2012WO2012122042A2 Peptide linkers for polypeptide compositions and methods for using same
09/13/2012WO2012121971A2 Locally released growth factors to mediate motor recovery after stroke
09/13/2012WO2012121740A1 Manufacturing and purification processes of complex proteins found in fraction iv
09/13/2012WO2012121679A1 Method of modulating phenotype of a renal cell cancer-associated monocyte or macrophage
09/13/2012WO2012121613A2 Use of edible composition
09/13/2012WO2012121529A2 Composition for nerve-cell or endothelial-cell regeneration comprising a ninjurin action suppressing agent
09/13/2012WO2012121485A2 Method for inducing in vivo migration of stem cell
09/13/2012WO2012121428A1 Fibroblast growth composition comprising a dipeptide as an active ingredient, and a product comprising the composition
09/13/2012WO2012121286A1 Skin-beautifying agent
09/13/2012WO2012121095A1 Enteral nutrient
09/13/2012WO2012121094A1 Albumin-containing intravenous injection
09/13/2012WO2012121058A1 Pharmaceutical composition that uses novel peptide that mimics tnf receptor loop peptide containing cross-linked structure
09/13/2012WO2012120535A2 A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
09/13/2012WO2012120516A1 Soy protein-based structures and uses thereof
09/13/2012WO2012120414A2 Edn3-like peptides and uses thereof
09/13/2012WO2012120129A1 Methods and pharmaceutical composition for the treatment of infectious diseases
09/13/2012WO2012120128A1 Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
09/13/2012WO2012120124A1 Factor xii inhibitors for the treatment of silent brain ischemia and ischemia of other organs
09/13/2012WO2012120038A2 Methods for diagnosing and/or treating sterility
09/13/2012WO2012119983A1 Treatment for ige-mediated disease
09/13/2012WO2012119980A1 Particles containing a growth factor, and uses thereof
09/13/2012WO2012119744A1 Novel fibrinolysis inhibitors and medical application thereof
09/13/2012WO2012119558A1 Method for removing/inactivating prion in glycoprotein
09/13/2012WO2012082821A3 Melanoma treatments
09/13/2012WO2012073047A3 Compositions and methods
09/13/2012WO2012071521A3 Adjuvant
09/13/2012WO2012067427A3 Pharmaceutical composition containing lk8 protein as an active ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration
09/13/2012WO2012061910A3 Main immunoprotective domains and epitopes of nucleoside hydrolase from leishmania (l) donovani for use in vaccination, immunotherapy and diagnosis
09/13/2012WO2012054425A3 Biodegradable particulate formulations
09/13/2012WO2011140086A3 Serum albumin binding molecules
09/13/2012US20120233726 Novel bacillus thuringiensis gene with lepidopteran activity
09/13/2012US20120232328 Drug activation system
09/13/2012US20120232284 Polymorph of a Pharmaceutical
09/13/2012US20120232125 Modulation of diacylglycerol acyltransferase 1 expression
09/13/2012US20120232107 Non-peptide antagonists of gastrin releasing peptide
09/13/2012US20120232024 Therapeutic uses of soluble alpha-klotho
09/13/2012US20120232023 Whey protein product and a method for its preparation
09/13/2012US20120232022 Botulinum toxin treatments
09/13/2012US20120232021 Peptide linkers for polypeptide compositions and methods for using same
09/13/2012US20120232020 METHOD OF IMPROVING TRANSPLANT FUNCTION USING SOLUBLE COMPLEMENT RECEPTOR TYPE I (sCR1)
09/13/2012US20120232019 Compositions and Methods for Treatment of Eye Disorders
09/13/2012US20120232018 Polycarbonates for delivery of drugs and methods of preparation thereof
09/13/2012US20120232017 Reduced volume formulation of glatiramer acetate and methods of administration
09/13/2012US20120232016 Method and system to detect and diagnose alzheimer's disease
09/13/2012US20120232015 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
09/13/2012US20120232014 Antithrombotic compounds
09/13/2012US20120232013 Cross-linked gelatin composition comprising a wetting agent
09/13/2012US20120232012 Compositions having antiangiogenic activity and uses thereof
09/13/2012US20120232011 Use of Rapamycin and Rapamycin Derivatives for the Treatment of Bone Loss
09/13/2012US20120232010 Compositions and Methods for Treating Bladder Cancer
1 ... 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 ... 3163